Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “HDR”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT01909388
What this trial is testing

Dose Escalation to Dominant Intraprostatic Lesions (DIL) With MRI-TRUS Fusion High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate Cancer
Alfonso Gomez-Iturriaga 15
Testing effectiveness (Phase 2)Active Not RecruitingNCT03775486
What this trial is testing

Study of Durvalumab+Olaparib or Durvalumab After Treatment With Durvalumab and Chemotherapy in Patients With Lung Cancer (ORION)

Who this might be right for
Non-small Cell Lung Cancer NSCLC
AstraZeneca 401
Not applicableUnknownNCT01851018
What this trial is testing

Toxicity Comparison Between Hypofractionated Radiotherapy With HDR Brachytherapy Boost Versus Standard Treatment

Who this might be right for
Prostate Cancer
CHU de Quebec-Universite Laval 30
Not applicableStudy completedNCT04247217
What this trial is testing

Immune Profiling After HDR in Local Relapsed Prostate Cancer

Who this might be right for
Prostate CancerPD-L1
Maastricht Radiation Oncology 10
Large-scale testing (Phase 3)Study completedNCT02220829
What this trial is testing

Comparative Study of Use of Alpha-Blockers to Treat Symptoms in Prostate Cancer Patients Undergoing Radiation Therapy

Who this might be right for
Urinary ProblemsProstate Cancer
Sir Mortimer B. Davis - Jewish General Hospital 148
Not applicableStudy completedNCT01605097
What this trial is testing

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule

Who this might be right for
Prostate Cancer
British Columbia Cancer Agency 26
Not applicableEnded earlyNCT03553212
What this trial is testing

Twice High Dose External Beam Radiotherapy by Image-guided Tomotherapy for Organ-confined Prostate Cancer Treatment Emulating High Dose Radiation (HDR) Brachytherapy

Who this might be right for
Prostate AdenocarcinomaRadiotherapy; ComplicationsTomotherapy
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 2
Not applicableNot Yet RecruitingNCT07825181
What this trial is testing

Homologous Recombination Repair Deficiency (HRD) Testing in Newly Diagnosed Advanced-stage Epithelial Ovarian Cancer in Italy

Who this might be right for
Epithelial Ovarian Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 1,125
Not applicableUnknownNCT04236752
What this trial is testing

Stereotactic Pelvic Brachytherapy With HDR Boost for Dose Escalation in High Tier Intermediate and High Risk Prostate ca

Who this might be right for
HIGH RISK PROSTATE CANCER
Sunnybrook Health Sciences Centre 33
Testing effectiveness (Phase 2)Study completedNCT03601923
What this trial is testing

Niraparib in Patients With Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Dana-Farber Cancer Institute 32
Testing effectiveness (Phase 2)Study completedNCT03377556
What this trial is testing

Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer

Who this might be right for
ATM Gene MutationATR Gene MutationBARD1 Gene Mutation+18 more
SWOG Cancer Research Network 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT04169841
What this trial is testing

Study Evaluating the Efficacy of a Double Immunotherapy Combined With Olaparib in Patients With Solid Cancers and Carriers of Homologous Recombination Repair Genes After Olaparib Treatment

Who this might be right for
Immunotherapy
Centre Georges Francois Leclerc 270
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07353437
What this trial is testing

Fluzoparib as Adjuvant Treatment in Patients With Germline Homologous Recombination Repair (HRR) Mutated Primary Breast Cancer (Flamenco)

Who this might be right for
Breast Cancer
Fudan University 334
Not applicableActive Not RecruitingNCT02918253
What this trial is testing

HDR Focal: Feasibility Study

Who this might be right for
Prostate Cancer
University Health Network, Toronto 60
Not applicableEnded earlyNCT03051802
What this trial is testing

Feasibility Study of Navigated Endoscopy for the Placement of High Dose Rate Brachytherapy Applicators in the Esophagus and Lung

Who this might be right for
Esophagus CancerLung Cancer
University Health Network, Toronto 1
Not applicableStudy completedNCT04962880
What this trial is testing

HRR Prevalence in LatAm PROSPECT Study

Who this might be right for
Castration-resistant Prostate Cancer
AstraZeneca 388
Testing effectiveness (Phase 2)Study completedNCT04174716
What this trial is testing

Basket Trial of IDX-1197, a PARP Inhibitor, in Patients With HRR Mutated Solid Tumors (VASTUS)

Who this might be right for
Solid TumorsHomologous Recombination Repair Gene MutationHomologous Recombination Deficiency
Idience Co., Ltd. 108
Not applicableLooking for participantsNCT06982469
What this trial is testing

High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy

Who this might be right for
Prostate CancerProstatectomyLocal Recurrence of Malignant Tumor of Prostate+2 more
Clinica Universidad de Navarra, Universidad de Navarra 20
Not applicableStudy completedNCT03424694
What this trial is testing

HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CR-CSSS Champlain-Charles-Le Moyne 199
Not applicableUnknownNCT05310370
What this trial is testing

HRD and Resistance to PAPPi in EOC Patients

Who this might be right for
Epithelial Ovarian CancerHomologous Recombination DeficiencyHomologous Recombination Repair Gene Mutation+4 more
Lei Li 400
Next Page